German guidelines on community-acquired acute bacterial meningitis in adults

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Matthias Klein - , Hospital of the Ludwig-Maximilians-University (LMU) Munich (Author)
  • Carsten Abdel-Hadi - , Red Cross Hospital Munich (Author)
  • Robert Bühler - , Bürgerspital Solothurn (Author)
  • Beatrice Grabein - , Hospital of the Ludwig-Maximilians-University (LMU) Munich (Author)
  • Jennifer Linn - , Institute and Polyclinic of Diagnostic and Interventional Neuroradiology (Author)
  • Roland Nau - , Third Institute of Physics, Faculty of Physics, Georg-August University (Author)
  • Bernd Salzberger - , University Children's Hospital Regensburg (KUNO) (Author)
  • Dirk Schlüter - , Hannover Medical School (MHH) (Author)
  • Konrad Schwager - , Klinik für Hals-Nasen-Ohrenkrankheiten (Author)
  • Hayrettin Tumani - , Ulm University Medical Center (Author)
  • Jörg Weber - , Klinikum Klagenfurt am Wörthersee (Author)
  • Hans-Walter Pfister - , Hospital of the Ludwig-Maximilians-University (LMU) Munich (Author)

Abstract

INTRODUCTION: The incidence of community-acquired acute bacterial meningitis has decreased during the last decades. However, outcome remains poor with a significant proportion of patients not surviving and up to 50% of survivors suffering from long-term sequelae. These guidelines were developed by the Deutsche Gesellschaft für Neurologie (DGN) under guidance of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) to guide physicians through diagnostics and treatment of adult patients with acute bacterial meningitis.

RECOMMENDATIONS: The most important recommendations are: (i) In patients with suspected acute bacterial meningitis, we recommend that lumbar cerebrospinal fluid (with simultaneous collection of serum to determine the cerebrospinal fluid-serum glucose index and blood cultures) is obtained immediately after the clinical examination (in the absence of severely impaired consciousness, focal neurological deficits, and/or new epileptic seizures). (ii) Next, we recommend application of dexamethasone and empiric antibiotics intravenously. (iii) The recommended initial empiric antibiotic regimen consists of ampicillin and a group 3a cephalosporin (e.g., ceftriaxone). (iv) In patients with severely impaired consciousness, new onset focal neurological deficits (e.g. hemiparesis) and/or patients with newly occurring epileptic seizures, we recommend that dexamethasone and antibiotics are started immediately after the collection of blood; we further recommend that -if the imaging findings do not indicate otherwise -a lumbar CSF sample is taken directly after imaging. (v) Due to the frequent occurrence of intracranial and systemic complications, we suggest that patients with acute bacterial meningitis are treated at an intensive care unit in the initial phase of the disease. In the case of impaired consciousness, we suggest that this is done at an intensive care unit with experience in the treatment of patients with severe CNS diseases.

CONCLUSIONS: The German S2k-guidelines give up to date recommendations for workup, diagnostics and treatment in adult patients with acute bacterial meningitis.

Details

Original languageEnglish
Article number44
JournalNeurological research and practice
Volume5
Issue number1
Publication statusPublished - 31 Aug 2023
Peer-reviewedYes

External IDs

PubMedCentral PMC10470134
Scopus 85169822659

Keywords